A simple home-cooked option of plain boiled rice with boiled chicken works well during recovery periods, as it is gentle on the gut and easy to absorb
Its important for patients to understand that GLP-1 medications are not a skinny shot, but a tool designed to support metabolic health through long-term weight management
Why dual-pathway targeting is more effective Single pathway limitations: GLP-1 alone eventually plateaus Body compensates over time Weight loss slows after 6-12 months Some people don't respond optimally Dual pathway advantages: Harder for body to compensate Multiple redundant systems targeted Sustained weight loss longer Better for non-responders to single therapy Mechanistic synergy: Amylin + GLP-1 naturally work together Both released after meals normally Physiologic combination Not forcing unnatural state Clinical implications: Patients who plateau on semaglutide benefit from adding cagrilintide Initial combination produces maximum results May prevent or delay weight regain Better long-term outcomes Cagrilintide and semaglutide dosing protocols Proper dosing ensures maximum efficacy with manageable side effects

The goal is to maximize the weight loss while being able to get patients off the drug in the future in a way that they dont feel like theyre going to regain the weight. Weight loss using GLP-1 medication varies by individual, but data suggest it is from 10% to 20% of total body weight over one year
We serve patients from Anaheim CA, Buena Park CA, La Palma CA, Cerritos CA, Cypress CA, Stanton CA, Garden Grove CA, Fullerton CA, Placentia CA, and Olive CA
Appetite and Metabolism: Activation of the MC4R is a well-established pathway for appetite suppression